Subscribe
shutterstock_1443758708_fotohelin
FotoHelin / Shutterstock.com
23 May 2022GenericsKareema Shaik and Jenny Pienaar

South Africa: homeopathy case clarifies ‘medicine’ definition

In August 2017, South Africa’s Minister of Health, Aaron Motsoaledi, issued updated General Regulations (“the Regulations”) in terms of the Medicines and Related Substances Act 101 of 1965.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
US, EU, India and South Africa reach COVID waiver ‘compromise’
16 March 2022   The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.
Africa
MSF urges South Africa to open access to COVID-19 generics
10 February 2022   Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
US, EU, India and South Africa reach COVID waiver ‘compromise’
16 March 2022   The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.
Africa
MSF urges South Africa to open access to COVID-19 generics
10 February 2022   Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.

More on this story

Big Pharma
US, EU, India and South Africa reach COVID waiver ‘compromise’
16 March 2022   The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.
Africa
MSF urges South Africa to open access to COVID-19 generics
10 February 2022   Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.

More features

Commercialising genomic tech in Nigeria
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
In vivo cell therapy: A world beyond ex vivo engineering
BMS notches legal win and FDA nod
Patent cliff: 5 blockbusters running out of road
‘Always new twists’: Bayer legal team on defending a $4bn drug
Fed Circ affirms generic’s litigation costs of $12m are tax-deductible
Interpreting the SPC manufacturing waiver: EU courts diverge